Remove Company Remove Ethics Remove Health Care Remove Innovation
article thumbnail

3M’s SVP of HR Kristen Ludgate on a Better Way to Attract Top Talent

HR Digest

To what extent is that down to a successful ‘Culture of Innovation?’ ’ Kristen Ludgate: 3M’s culture of innovation definitely comes through in the experience and approach of 3Mers during their day-to-day work. The HR Digest: 3M is said to have a passionate work culture fit for the industry’s most driven workers.

article thumbnail

Task Shifting Could Help Lower Costs in U.S. Health Care

Harvard Business Review

The task shifting logic also applies to health care. health care. Through a process we’ve termed “reverse innovation” these practices can be brought to other countries, including the United States, where health care costs are out of control. Innovation & Entrepreneurship Book.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Connecting with Patients

Michael Lee Stallard

I’ve previously written that connection is critical to health care and cited the examples of Dr. Herb Pardes at New York-Presbyterian and my own observations during my wife Katie’s battles with breast and advanced ovarian cancer. Katie is cancer free today. why is everyone smiling?

McCarthy 199
article thumbnail

How Ethical Are You?

Harvard Business Review

"Is the Ethics of Business Changing?" In it, they compared the results of a situational ethics test that 1,200 HBR readers had taken the previous year with a similar test readers had taken back in 1961. Acceptable if other executives in the same company do it. Unacceptable regardless of circumstances. Would you: Do nothing.

Ethics 12
article thumbnail

Big Pharma's Hidden Business Model and How Your Company Funds It

Harvard Business Review

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. Negative results are usually not published at all.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Merck and Co. Integration is key.

article thumbnail

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Harvard Business Review

The Leading Edge of Health Care. How the most innovative providers are creating value. National Institutes of Health, but the reverse is less clear; biopharmaceutical companies, too, participate in basic research that advances our understanding of mechanisms of disease and treatment. Insight Center.